PRO Peptide Panel

Advanced At-Home Peptide Therapy & Health Monitoring | 25 Biomarkers

Monitor Your Biomarkers. Optimize Your Protocol. Support Your Recovery.

The PRO Peptide Panel is a comprehensive at-home blood test designed to evaluate important hormone, growth factor, metabolic, inflammatory, and organ-function biomarkers in individuals utilizing peptide therapy or participating in medically supervised health optimization programs.

With 25 biomarkers for men or women, this panel provides valuable information to help establish baseline laboratory values, monitor physiological responses, and identify changes that may require clinical attention.

Whether you're beginning a peptide protocol, evaluating your response to an existing treatment, or monitoring long-term metabolic and hormonal health, the PRO Peptide Panel provides convenient laboratory testing supported by clinical oversight through PRO Sports Medicine.

What Does the Peptide Panel Evaluate?

Complete Blood Count (CBC) — 10 Biomarkers

• Hematocrit (HCT)

• Hemoglobin (HGB)

• Red Blood Cell Count (RBC)

• White Blood Cell Count (WBC)

• Platelet Count (PLT)

• Mean Corpuscular Volume (MCV)

• Mean Corpuscular Hemoglobin (MCH)

• Mean Corpuscular Hemoglobin Concentration (MCHC)

• Red Cell Distribution Width (RDW)

• Mean Platelet Volume (MPV)

These measurements help evaluate red blood cell production, oxygen-carrying capacity, and other hematologic indicators.

Why Blood Count Monitoring Matters

Certain hormonal therapies and underlying medical conditions can influence blood cell production and hematologic measurements.

Monitoring these markers helps establish baseline values and identify changes that may warrant additional evaluation.

The panel includes a CBC without differential.

Metabolic & Organ Function — 8 Biomarkers

• Alanine Aminotransferase (ALT)

• Aspartate Aminotransferase (AST)

• Alkaline Phosphatase (ALP)

• Albumin

• Blood Urea Nitrogen (BUN)

• Creatinine

• Total Bilirubin

• Total Protein

These biomarkers provide information about liver function, kidney function, protein metabolism, and overall metabolic health.

Liver Function Monitoring

ALT, AST, ALP, and bilirubin help evaluate liver-related biochemical activity and identify abnormalities that may require further assessment.

Kidney Function Monitoring

BUN and creatinine provide information relevant to kidney function and metabolic waste processing.

Protein Metabolism

Albumin and total protein help assess circulating protein status and provide additional context for nutritional and organ-function evaluation.

Hormone & Growth Factor Monitoring — 4 Biomarkers

• Total Testosterone

• Sex Hormone-Binding Globulin (SHBG)

• Thyroid-Stimulating Hormone (TSH)

• Insulin-Like Growth Factor 1 (IGF-1)

These measurements provide important information about endocrine function, hormone regulation, and growth hormone pathway activity.

Total Testosterone

Measures circulating testosterone, an important hormone associated with muscle maintenance, bone health, reproductive function, and metabolic health.

Sex Hormone-Binding Globulin (SHBG)

Measures the primary circulating binding protein for sex hormones and provides additional context when interpreting testosterone levels.

Thyroid-Stimulating Hormone (TSH)

Evaluates thyroid regulation and helps identify potential thyroid dysfunction that may influence energy, metabolism, and body composition.

Insulin-Like Growth Factor 1 (IGF-1)

IGF-1 is an important biomarker associated with growth hormone signaling, tissue growth, and metabolic regulation.

Why IGF-1 Monitoring Matters During Peptide Therapy

Certain peptide therapies, particularly growth hormone secretagogues and growth hormone-releasing hormone analogs, can influence growth hormone signaling and IGF-1 concentrations.

Monitoring IGF-1 may help clinicians evaluate biological responses to therapies involving the growth hormone axis and identify elevations that warrant additional evaluation.

Examples of peptides associated with growth hormone pathway activity include:

• Tesamorelin

• Ipamorelin

• CJC-1295

• Other growth hormone secretagogues

IGF-1 is only one component of treatment monitoring and should be interpreted alongside symptoms, medical history, and other clinical findings.

Inflammation & Glucose Regulation — 2 Biomarkers

High-Sensitivity C-Reactive Protein (hsCRP)

Measures a circulating marker of systemic inflammation.

Elevated hsCRP may reflect inflammatory activity associated with infections, chronic inflammatory conditions, cardiometabolic risk, or other physiological processes.

Hemoglobin A1c (HbA1c)

Estimates average blood glucose over approximately the preceding two to three months.

HbA1c helps evaluate glucose regulation, metabolic health, and potential changes associated with weight management or other medical treatments.

These biomarkers provide additional information when evaluating metabolic health and inflammatory status during ongoing treatment.

Sex-Specific Monitoring

The PRO Peptide Panel includes one additional biomarker based on the selected male or female configuration.

Male Panel — Prostate-Specific Antigen (PSA)

PSA provides information relevant to prostate health and may be particularly useful when clinically indicated in patients also receiving testosterone therapy.

Elevated PSA requires interpretation based on age, clinical history, medications, and other relevant factors.

Female Panel — Progesterone

Progesterone provides information about reproductive hormone activity and may be useful when evaluating menstrual cycle physiology, reproductive hormone status, or hormone treatment.

Interpretation depends on menstrual cycle timing, menopausal status, and hormone medication use.

Total: 25 biomarkers per male or female panel.

Who Should Consider the PRO Peptide Panel?

The PRO Peptide Panel may be appropriate for individuals who want to:

• Establish baseline laboratory values before beginning a peptide therapy program.

• Monitor selected biomarkers during medically supervised peptide treatment.

• Evaluate IGF-1 levels during growth hormone pathway-related therapies.

• Monitor liver and kidney function.

• Assess testosterone and thyroid-related biomarkers.

• Track inflammation and long-term glucose regulation.

• Support ongoing clinical decision-making during a health optimization program.

Convenient At-Home Blood Testing

The PRO Peptide Panel uses an at-home capillary blood collection system, allowing patients to collect samples without scheduling a traditional laboratory blood draw.

Your Testing Kit Includes:

• At-home blood collection supplies

• EasyDraw capillary blood collection devices

• Collection tubes and specimen packaging

• Sample preparation and return shipping materials

• Laboratory processing

• Digital laboratory results

The Peptide Panel requires two EasyDraw collection devices per testing kit.

Patients receive instructions for properly collecting and returning their samples.

Your Laboratory Results

Once testing is completed, results are made available digitally.

Your report provides individual biomarker results, laboratory reference ranges, and information to help you better understand the findings.

Results may be reviewed with PRO Sports Medicine to identify relevant abnormalities, discuss treatment considerations, and determine whether additional testing or follow-up is appropriate.

PRO Foundations Clinical Oversight

The PRO Peptide Panel can be integrated into the PRO Foundations Program, providing a more comprehensive approach to personalized health monitoring.

Active PRO Foundations Members Receive:

• Preferred member pricing on eligible laboratory panels

• Clinical provider review of laboratory results

• Integration of findings with existing treatment protocols

• Recommendations for appropriate follow-up testing

• Ongoing health and performance monitoring through the PRO Foundations Program

Clinical Laboratory Review Pricing

• PRO Foundations Members: Included

• Nonmembers: $79 per review

Recommended Testing Frequency

Laboratory monitoring intervals are individualized based on the specific treatment, medical history, baseline results, and clinical response.

Baseline Testing

Before beginning a new peptide protocol, when clinically indicated, to establish relevant laboratory values.

Interval Monitoring

Follow-up testing may be considered during treatment to assess changes in selected biomarkers.

Ongoing Monitoring

Additional testing may be recommended based on individual health goals, treatment duration, or abnormal laboratory findings.

Not every peptide treatment requires the same laboratory monitoring strategy.

Why Choose the PRO Peptide Panel?

The PRO Peptide Panel combines convenient at-home sample collection with targeted biomarker assessment and access to clinical oversight.

Rather than relying exclusively on symptoms or subjective treatment responses, laboratory testing provides objective physiological measurements that can help inform appropriate clinical decisions.

Monitor Your Health. Understand Your Biomarkers. Make Informed Treatment Decisions.

Important Information

This panel is intended for health assessment and clinical monitoring. It does not establish the effectiveness or safety of any particular peptide therapy. Some peptides used in wellness and performance settings are investigational and are not FDA-approved for human therapeutic use. Laboratory results must be interpreted within the context of individual medical history, examination findings, and treatment goals. Testing does not replace appropriate medical evaluation.